1 / 42

Infections in OB/GYN: Vaginitis, STIs

Infections in OB/GYN: Vaginitis, STIs. Lisa Rahangdale, MD, MPH Dept. of OB/GYN. Objectives. Diagnose and treat a patient with vaginitis Interpret a wet prep Differentiate the signs and symptoms, PE findings, diagnostic evaluation of the following STI’s: Gonnorhea Chlamydia Herpes

Download Presentation

Infections in OB/GYN: Vaginitis, STIs

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Infections in OB/GYN: Vaginitis, STIs Lisa Rahangdale, MD, MPH Dept. of OB/GYN

  2. Objectives • Diagnose and treat a patient with vaginitis • Interpret a wet prep • Differentiate the signs and symptoms, PE findings, diagnostic evaluation of the following STI’s: • Gonnorhea • Chlamydia • Herpes • Syphillis • HPV • Describe pathogenesis, signs and symptoms and management of PID

  3. 26 yo 2 wk hx vag DC • Differential Diagnosis • HPI • Pertinent PMH • Pelvic Exam • MicroscopyLaboratory • Treatment • Counseling

  4. Vaginal Discharge DDXS • Candidiasis • Bacterial Vaginosis • Trichomonas • Atrophic • Physiologic (Leukorrhea) • Mucopurulent Cervicitis • Uncommon • Foreign Body • Desquamative

  5. HPI • Age • Characteristics of discharge • color, odor, consistency • Symptoms • Itching, burning • erythema, bumps • Bleeding, pain • Prior occurences, treatments • Risk factors • Sexual activity, medications, PMH

  6. PMH • Pregnancy • Menopause • Immunosuppression • Diabetes, HIV, medications

  7. Pelvic exam

  8. Microscopy

  9. Pelvic Exam

  10. Microscopy

  11. Treatment & Counseling • Rx: Metronidazole 2 gm po X 1 Tinidazole 2 gm PO x 1 • Counseling • Partner treatment • Safe sex

  12. Pelvic exam

  13. Microscopy

  14. Pelvic exam

  15. Neisseria gonnorhea • Symptoms • Arise 3-5 days after exposure • Initially so mild as to be overlooked • Malodorous, purulent vaginal discharge • Physical Exam • Mucopurulent discharge flowing from cervix • Cervical Motion Tenderness

  16. Gonorrhea Rx Ceftriaxone 125 mg IM in a single doseORCefixime400 mg orally in a single dose PLUS Tx FOR CHLAMYDIA IF NOT RULED OUT Do NOT use Quinolones in U.S. - resistant GC common

  17. Chlamydia S/Sx/Dxs • Usually asymptomatic • Best to screen susceptible young women • Mucopurulent cervicitis • Intermenstrual bleeding • Friable cervix • Postcoital bleeding • Elisa or DNA probe (difficult to culture)

  18. Chlamydia Rx • Uncomplicated cervicitis (no PID) • Azithromycin 1 gm po OR • Doxycycline 100 mg BID for 7 days • Repeat testing in 3 mons • Annual screen in age < 25

  19. Chlamydia in Pregnancy • Azithromycin 1 g orally in a single dose ORAmoxicillin 500 mg orally three times a day for 7 days (2006 - Poor efficacy of erythromycin – now alternative regimen) • Test of cure in 3 weeks

  20. 21 YO presents with RLQ pain • Differential diagnosis • GYN • OB • GI • Urologic • MSK • She has CMT on pelvic examination. Does this rule anything out?

  21. HPI • LMP = 5 days ago • Pelvic pain, vaginal discharge x 2 days • New sexual partner in last 3 months • Uses condoms “all of the time except sometimes when we forget.”

  22. Pelvic Inflammatory Disease • Polymicrobial • Initiated by GC, Chlamydia, Mycoplasmas • Overgrowth by anaerobic bacteria, GNRs and other vaginal flora (Strep, Peptostrep) • Bacterial Vaginosis - associated with PID

  23. PID Symptoms • Acute or chronic abdominal/pelvic pain • Deep Dyspareunia • Fever and Chills • Nausea and Vomiting • Epigastric or RUQ pain (perihepatitis)

  24. PID Physical Diagnosis • Minimum criteria: one or more of the following- • Uterine Tenderness • Cervical Motion Tenderness • Adnexal Tenderness • Additional support: • Fever > 101/38.4 • Mucopurulent Discharge • Abdominal tenderness +/- rebound • Adnexal fullness or mass • Hydrosalpinx or TOA

  25. PID Diagnostic Tests • WBC may be elevated, *often WNL • ESR >40, Elevated CRP-neither reliable • Ultrasound • Hydrosalpinx or a TuboOvarian Complex/Abcess • Fluid in Culdesac nonspecific • Fluid in Morrison’s Pouch is suggestive if associated with epigastric/RUQ pain

  26. “Am I going to have to go the hospital?” • Inpatient tx Criteria • Peritoneal signs • Surgical emergencies not excluded (appy) • Unable to tolerate/comply with oral Rx • Failed OP tx • Nausea, Vomiting, High Fever • TuboOvarian Abcess • Pregnancy 2006 CDC STD guidelines

  27. PID Treatment • Needs to incorporate Rx of GC and Chlamydia (tests pending) • Outpatient • Ceftriaxone 250mg IM + Doxycycline x 14 d w/ or w/out Metronidazole 500mg bid x 14 d • Levofloxacin 500 mg QD or Ofloxacin 400 mg BID + Metronidazole x14 days (No Quinolone unless allergy) Regimens:http://www.cdc.gov/std/treatment/2006/pid.htm

  28. PID Inpatient Rx • Cefoxitin 2 gm IV q 6 hr • OR Cefotetan 2 gm q 12 hr • Plus • Doxycycline 100mg IV or po q 12 hr • For maximal anaerobic coverage/penetration of TOA: • Clindamycin 900mg q 8 hr and • Gentamycin 2 mg/kg then 1.5mg/kg q 8 hr

  29. PID SEQUELAE Pelvic Adhesions chronic pelvic pain, dyspareunia infertility ectopic pregnancy Empiric Treatment Suspected Chlamydia, GC or PID Deemed valuable in preventing sequelae “Am I going to be OK after I take these antibiotics?”

  30. Recommended Screening • GC/Chlamydia: • women < 25 (**remember urine testing!) • Pregnancy • Syphilis • Pregnancy • HIV • age 13-64, (? Screening time interval) • One STD, consider screening for others • PE, Wet mounts, PAP, GC/CT, VDRL, HIV

  31. 24 yo G 0 lesion on vulva • HPI • Pertinent review of systems • Focused exam • Laboratory • Treatment • Counseling re partner

  32. Genital Ulcers Herpes Syphilis Chanchroid Lymphogranuloma Venereum Granuloma Inguinale Vulvar lesions HPV Molluscum Contagiosum Pediculosis Pubis Scabies Vulvar lesions: DDxs

  33. Herpes • Herpes Simplex Virus I and II • Spread by direct contact • “mucous membrane to mucous membrane” • Painful ulcers • Irregular border on erythematous base • Exquisitely tender to Qtip exam • Culture, PCR low sensitivity after Day 2

  34. Herpes • Primary • Systemic symptoms • Multiple lesions • Urinary retention • Nonprimary First Episode • Few lesions • No systemic symptoms • preexisting Ab

  35. Herpes Rx • First Episode • Acyclovir, famciclovir, valcyclovir x 7–10 days • Recurrent Episodic Rx: • In prodrome or w/in 1 day of lesion) • 1-5 day regimens • Suppressive therapy • Important for last 4 weeks of pregnancy

  36. Syphilis • Treponema Pallidum- spirochete • Direct contact with chancre: cervix, vagina, vulva, any mucous membrane • Painless ulceration • Reddish brown surface, depressed center • Raised indurated edges • Dx: smear for DFA, Serologic Testing

  37. Syphilis Stages • Clinically Manifest vs. Latent • Primary- painless ulcer • chancre must be present for at least 7 days for VDRL to be positive • Secondary- • Rash (diffuse asymptomatic maculopapular) lymphadenopathy, low grade fever, HA, malaise, 30% have mucocutaneous lesions • Tertiary gummas develop in CNS, aorta

  38. Primary & Secondary Syph

  39. Latent Syphilis • Definition: Asx, found on screen • Early 1 year duration • Late >1 year or unknown duration • Testing • Screening: VDRL, RPR- nontreponemal • Confirmatory: FTA, MHATP- treponemal

  40. Syphilis Treatment • Primary, Secondary and Early Latent • Benzathine Penicillin 2.4 mU IM • Tertiary, Late Latent • Benzathine Penicillin 2.4 mU IM q week X 3 • Organisms are dividing more slowly later on • NeuroSyphilis • IV Pen G for 10-14 days

  41. Vulvar Lesions • Human Papilloma Virus • Molluscum Contagiosum • Pediculosis Pubis • Scabies

  42. HPV – genital warts • Most common STD • HPV 6 and 11 – low risk types • Verruccous, pink/skin colored, papillaform • DDxs: condyloma lata, squamous cell ca, other • Treatment: • Chemical/physical destruction (cryo, podophyllin, 5% podofilox, TCA) • Immune modulation (imiquimod) • Excision • Laser • Other: 5-FU, interferon-alpha, sinecatchins • High rate of RECURRENCE

More Related